ArticleOncoTargets and therapy2021

PD-L1 Expression and Outcome in Patients with Metastatic Non-Small Cell Lung Cancer and EGFR Mutations Receiving EGFR-TKI as Frontline Treatment.

Cheng-Yu Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.